Changeflow GovPing Pharma & Drug Safety Heparan-N-sulfatase purification via multi-mode...
Routine Notice Added Final

Heparan-N-sulfatase purification via multi-mode chromatography

Favicon for changeflow.com ChangeBridge: Patent Apps - Peptides (C07K)
Published April 2nd, 2026
Detected April 2nd, 2026
Email

Summary

The USPTO published patent application US20260092264A1 on April 2, 2026, disclosing a novel method for purifying heparan-N-sulfatase using multi-mode chromatography combined with caprylate precipitation. Invented by six researchers, the method removes host cell proteins and improves purity and stability of the enzyme for potential pharmaceutical applications.

What changed

The USPTO published application US20260092264A1, disclosing a method for purifying heparan-N-sulfatase from solutions containing impurities. The method combines multi-mode chromatography to obtain an eluate, followed by caprylate precipitation to produce a purified supernatant. The claimed invention is classified under CPC codes C12N 9/14, C07K 1/165, C07K 1/30, C07K 1/34, and C12Y 310/01001, indicating applications in enzyme chemistry and protein purification.

Patent applications do not impose compliance obligations on industry. For biopharmaceutical manufacturers developing heparan-N-sulfatase-based therapeutics, this publication represents potential prior art that could affect freedom-to-operate assessments. Research and development teams working on enzyme purification processes should review the disclosed methods for potential licensing opportunities or to assess patent landscape implications.

Source document (simplified)

← USPTO Patent Applications

NOVEL PROCESS FOR PURIFYING HEPARAN-N-SULFATASE

Application US20260092264A1 Kind: A1 Apr 02, 2026

Inventors

Kwanyoung KO, Dasom KIM, Sulgi YOO, Geunhye YEO, Minjung KIM, Dong Kyu JIN

Abstract

The present invention is related to a method for purifying heparan-N-sulfatase from a heparan-N-sulfatase-containing solution including at least one impurity, the method comprising performing multi-mode chromatography (MMC) to obtain an eluate; and performing caprylate precipitation to obtain a supernatant. The method according to the present invention is capable of very efficiently removing HCP (host cell proteins) and of greatly improving the purity and stability of purified heparan-N-sulfatase.

CPC Classifications

C12N 9/14 C07K 1/165 C07K 1/30 C07K 1/34 C12Y 310/01001

Filing Date

2023-09-18

Application No.

19110710

View original document →

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260092264A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent Application
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Research & Development
Topics
Healthcare Pharmaceuticals

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Peptides (C07K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.